Table 4.
Logistic regression to predict NAC involvement by tumorsa
Parameter | Estimate | Standard error | Wald χ2 | P > χ2 |
---|---|---|---|---|
Intercept | −4.0670 | 0.6599 | 37.9797 | <0.0001 |
Two-quadrant involvement | 1.2319 | 0.5478 | 5.0574 | 0.0245 |
Three-quadrant involvement | 1.1669 | 1.1390 | 1.0494 | 0.3056 |
Four-quadrant involvement | 3.2843 | 0.6635 | 24.5053 | <0.0001 |
Central location | 2.2656 | 0.5148 | 19.3679 | <0.0001 |
HER2 positive | 0.7979 | 0.4398 | 3.2918 | 0.0696 |
Nuclear grade 2 | 0.1695 | 0.6163 | 0.0757 | 0.8732 |
Nuclear grade 3 | 0.0013 | 0.6208 | 1.1348 | 0.2867 |
aIntercept = log(P/(1 − P)) for a reference patient. The reference patient is defined as the patient having zero on all of the variables. In our case, the reference patient is the patient with a tumor that has one quadrant involvement, no central location, negative for HER2 overexpression, and a nuclear grade of one. Thus, in our case, −4.0670 = log(P/(1 − P)) where P = 1.68%. It means for a reference patient, her chance of NAC involvement is 1.68%. P indicates the probability of the NAC involvement